285 related articles for article (PubMed ID: 19697885)
1. [Recent trends in the pathophysiology and treatment of pituitary adenomas].
Matsuno A
Brain Nerve; 2009 Aug; 61(8):957-62. PubMed ID: 19697885
[TBL] [Abstract][Full Text] [Related]
2. The role of hypothalamic hormones in the pathogenesis of pituitary adenomas.
Asa SL
Pathol Res Pract; 1991 Jun; 187(5):581-3. PubMed ID: 1923953
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of pituitary adenomas].
Mezosi E; Nemes O
Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
5. [Novel pharmacologic therapies in acromegaly].
Góth M; Hubina E; Kovács L; Szabolcs I
Orv Hetil; 2002 May; 143(19 Suppl):1057-62. PubMed ID: 12063860
[TBL] [Abstract][Full Text] [Related]
6. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
[TBL] [Abstract][Full Text] [Related]
7. Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation‒Positive Child.
Dutta P; Reddy KS; Rai A; Madugundu AK; Solanki HS; Bhansali A; Radotra BD; Kumar N; Collier D; Iacovazzo D; Gupta P; Raja R; Gowda H; Pandey A; Devgun JS; Korbonits M
J Clin Endocrinol Metab; 2019 Aug; 104(8):3539-3544. PubMed ID: 31125088
[TBL] [Abstract][Full Text] [Related]
8. Pituitary adenomas in childhood and adolescence. Clinical analysis of 10 cases.
De Menis E; Visentin A; Billeci D; Tramontin P; Agostini S; Marton E; Conte N
J Endocrinol Invest; 2001 Feb; 24(2):92-7. PubMed ID: 11263478
[TBL] [Abstract][Full Text] [Related]
9. Pituitary somatotroph adenoma producing growth hormone (GH)-releasing hormone (GHRH) with an elevated plasma GHRH concentration: a model case for autocrine and paracrine regulation of GH secretion by GHRH.
Matsuno A; Katakami H; Sanno N; Ogino Y; Osamura RY; Matsukura S; Shimizu N; Nagashima T
J Clin Endocrinol Metab; 1999 Sep; 84(9):3241-7. PubMed ID: 10487694
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of pituitary tumors.
Kreutzer J; Fahlbusch R
Curr Opin Neurol; 2004 Dec; 17(6):693-703. PubMed ID: 15542978
[TBL] [Abstract][Full Text] [Related]
11. Expression of prolactin-releasing peptide and its receptor messenger ribonucleic acid in normal human pituitary and pituitary adenomas.
Zhang X; Danila DC; Katai M; Swearingen B; Klibanski A
J Clin Endocrinol Metab; 1999 Dec; 84(12):4652-5. PubMed ID: 10599733
[TBL] [Abstract][Full Text] [Related]
12. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
13. Pancreastatin secretion by pituitary adenomas and regulation of chromogranin B mRNA expression.
Jin L; Scheithauer BW; Young WF; Davis DH; Klee GG; Lloyd RV
Am J Pathol; 1996 Jun; 148(6):2057-66. PubMed ID: 8669489
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone-releasing hormone transcripts in human pituitary adenomas.
Levy A; Lightman SL
J Clin Endocrinol Metab; 1992 Jun; 74(6):1474-6. PubMed ID: 1350590
[TBL] [Abstract][Full Text] [Related]
15. Aggressive Pituitary Adenomas: The Dark Side of the Moon.
Priola SM; Esposito F; Cannavò S; Conti A; Abbritti RV; Barresi V; Baldari S; Ferraù F; Germanò A; Tomasello F; Angileri FF
World Neurosurg; 2017 Jan; 97():140-155. PubMed ID: 27713064
[TBL] [Abstract][Full Text] [Related]
16. Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas.
Saveanu A; Jaquet P; Brue T; Barlier A
Mol Cell Endocrinol; 2008 May; 286(1-2):206-13. PubMed ID: 18241980
[TBL] [Abstract][Full Text] [Related]
17. Neuronal nitric oxide synthase gene expression in human pituitary tumours: a possible association with somatotroph adenomas and growth hormone-releasing hormone gene expression.
Ueta Y; Levy A; Powell MP; Lightman SL; Kinoshita Y; Yokota A; Shibuya I; Yamashita H
Clin Endocrinol (Oxf); 1998 Jul; 49(1):29-38. PubMed ID: 9797844
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of pituitary Cushing's syndrome. Pituitary versus hypothalamic.
Biller BM
Endocrinol Metab Clin North Am; 1994 Sep; 23(3):547-54. PubMed ID: 7805653
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic endonasal transsphenoidal removal of recurrent and regrowing pituitary adenomas: experience on a 59-patient series.
Cavallo LM; Solari D; Tasiou A; Esposito F; de Angelis M; D'Enza AI; Cappabianca P
World Neurosurg; 2013; 80(3-4):342-50. PubMed ID: 23046913
[TBL] [Abstract][Full Text] [Related]
20. Prolactin (PRL)-releasing peptide stimulates PRL secretion from human fetal pituitary cultures and growth hormone release from cultured pituitary adenomas.
Rubinek T; Hadani M; Barkai G; Melmed S; Shimon I
J Clin Endocrinol Metab; 2001 Jun; 86(6):2826-30. PubMed ID: 11397894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
